Obtainable for over a yr
Over 1.5million adults within the UK tried weight reduction medication in 2024-25. Many swear by them, however they’ve been related to negative effects together with nausea and, in some circumstances, extraordinarily painful gallstones. However what does the proof really inform us, and what’s the wider affect on the best way we view our our bodies in society?
James Gallagher is joined by Professor of Cardiometabolic Drugs on the College of Glasgow Naveed Sattar, Dr Beverley O’Hara, Lecturer in Public Well being Vitamin at Leeds Beckett College, and Dr Margaret McCartney, resident Inside Well being GP. They talk about what the proof tells us in regards to the potential identified negative effects of those weight reduction medication, and the potential affect their use has on our view of weight problems as a society. We additionally hear from Sarah Le Brocq, who has struggled with weight problems all her grownup life and has been on these medication for the previous 2-3 years about her experiences.
Margaret McCartney has no conflicts of curiosity to declare.
Beverley O’Hara has no conflicts of curiosity to declare. She has 2 roles with the Affiliation for the Examine of Weight problems (voluntary tutorial positions).
Naveed Sattar has consulted for and/or acquired speaker honoraria from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gan & Lee, GlaxoSmithKline, Hanmi Prescription drugs, Kailera, Mass Medicines, Menarini-Ricerche, Metsera, Novo Nordisk, Pfizer, Regeneron, Roche, UCB Pharma, and Verdiva Bio; and acquired grant assist paid to his College from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche.
Presenter: James Gallagher
Producer: Hannah Fisher
Researcher: Tom Hunt
Manufacturing coordinator: Stuart Legal guidelines
Content material Editor: Ilan Goodman
Programme Web site
Leave a Reply